Depression treatment for Lake Worth Beach — measurement-based, 22 minutes away.

RECO Health is fourteen miles south of Lake Worth Beach on I-95 — a twenty-two-minute drive from Bryant Park, College Park, and downtown. Depression treatment here is anchored in measurement-based care: DSM-5-TR diagnosis, serial PHQ-9 tracking, and pharmacology sequenced by evidence rather than habit. When two adequate antidepressant trials haven't produced remission, in-house rTMS and IV ketamine are available on defined protocols — not deferred to an outside referral six months from now.

Lake Worth Beach sits fourteen miles north of RECO Health’s Delray Beach campus — a twenty-two-minute drive down I-95 to the Linton Boulevard exit, longer on A1A during season. Clients from Bryant Park, College Park, Mango Groves, Parrot Cove, and downtown Lake Worth commonly commute to intensive outpatient a few days a week and step down through on-campus sober living during the partial hospitalization phase, preserving proximity to the community they call home without giving up clinical continuity. Depression treatment at RECO is anchored in measurement-based care: every plan begins with a DSM-5-TR diagnostic formulation and a baseline PHQ-9, and every subsequent decision is documented against that trajectory rather than clinical impression.

Diagnostic formulation and severity staging

The initial evaluation is a structured differential, not a checkbox intake. RECO’s psychiatric team distinguishes major depressive disorder from persistent depressive disorder (dysthymia), bipolar II depression, adjustment disorder with depressed mood, and depression secondary to a general medical condition or substance use. A missed bipolar diagnosis is the single most common reason antidepressants appear to “stop working” after early gains; the Mood Disorder Questionnaire is administered whenever family history, prior response pattern, or hypomanic symptomatology raises concern.

Severity is anchored to the PHQ-9 rather than global impression. Scores of 20 or higher, active suicidal ideation on the Columbia Suicide Severity Rating Scale (C-SSRS), or acute functional collapse route the client to partial hospitalization; moderate presentations with PHQ-9 in the 10 to 19 range are matched to intensive outpatient. Baseline labs — TSH, free T4, B12, folate, vitamin D, and CBC with a metabolic panel — rule out treatable medical contributors before a fourth medication trial is considered. Concurrent substance use is screened with the AUDIT-C and DAST-10, since untreated alcohol or benzodiazepine use will blunt the response to any antidepressant regimen.

Pharmacology sequenced by evidence, not habit

First-line pharmacotherapy for major depression is a selective serotonin reuptake inhibitor — sertraline or escitalopram most often — or a serotonin-norepinephrine reuptake inhibitor such as venlafaxine or duloxetine when prominent fatigue, pain, or anxious distress is part of the presentation. Each agent is titrated to a therapeutic dose and observed for four to six weeks before it is called a failed trial. Subtherapeutic dosing masquerading as treatment resistance is one of the most common patterns RECO’s psychiatrists correct in transfer-of-care cases.

Partial responders are augmented before they are switched. Aripiprazole at 2 to 5 mg, lithium at serum levels of 0.6 to 0.8 mEq/L, or bupropion added to an SSRI each carry stronger evidence than serial monotherapy substitutions. Quetiapine XR is available where sedation and sleep architecture need correction simultaneously, and buspirone remains an option for anxious depression when augmentation with an atypical is not tolerated. When two adequate trials have failed — the STAR*D threshold for treatment-resistant depression — the plan shifts to interventional options rather than a fifth antidepressant. Every dose change and response window is documented alongside a serial PHQ-9, so the trajectory drives the next decision.

Behavioral therapy modalities with evidence for depression

Therapy at RECO is delivered to protocol, not as a loose collection of techniques. Cognitive Behavioral Therapy for depression targets cognitive distortions and behavioral withdrawal across a defined arc of sessions, with between-session assignments and thought records that anchor the work. Behavioral Activation is run in parallel, particularly for clients whose anhedonia and inertia make cognitive work premature; scheduled mastery and pleasure activities are titrated the way medication is.

Interpersonal Therapy is the modality of choice when depression is driven by grief, role transition, or interpersonal conflict — presentations common in clients navigating divorce, adult-child estrangement, or bereavement. For clients whose depression is trauma-linked, Cognitive Processing Therapy or EMDR is layered into the treatment plan; treating a depressive syndrome without addressing the trauma that maintains it produces the brittle remissions that relapse within months. Acceptance and Commitment Therapy and DBT skills groups round out the milieu, particularly for clients with emotion regulation deficits, chronic suicidality, or a co-occurring substance use disorder where Motivational Interviewing is folded into the individual work.

Escalation pathway when medication and therapy aren’t enough

Roughly a third of clients with major depression do not achieve remission with two adequate antidepressant trials. RECO’s escalation pathway is defined in advance so the transition doesn’t drift. Repetitive transcranial magnetic stimulation is delivered at 10 Hz over the left dorsolateral prefrontal cortex, 3,000 pulses per session at 120% of resting motor threshold, on the standard 36-session FDA-cleared protocol; intermittent theta-burst is available where scheduling requires a three-minute session. rTMS is non-sedating, has no cognitive side effects, and requires no escort home.

For clients whose suicidality, functional collapse, or catatonic features do not allow the six-week window rTMS requires, IV ketamine is offered — 0.5 mg/kg infused over 40 minutes, a six-infusion induction across two to three weeks, with maintenance dosing titrated to PHQ-9 and MADRS response. Esketamine (Spravato) is available where a REMS-monitored intranasal protocol is clinically or logistically preferable. Escalation happens on a schedule, not after months of drift through subtherapeutic combinations, and every interventional decision is made by the treating psychiatrist rather than deferred to an outside referral.

What to expect on the first visit

The first appointment is a ninety-minute psychiatric evaluation paired with a licensed clinician’s biopsychosocial assessment. The psychiatrist takes a full diagnostic history, reviews prior medication trials with specific attention to dose and duration, and administers or re-administers the PHQ-9, GAD-7, and C-SSRS. If labs have not been drawn in the last six months, they are ordered the same day, and any prior records from an outside prescriber are requested with the client’s release.

Clients leave the first visit with a working DSM-5-TR diagnosis, a written treatment plan, a level-of-care recommendation (PHP or IOP), and — when medication is indicated — a prescription with a scheduled follow-up inside two weeks. Clients transferring from an outside prescriber are not asked to stop medication cold; changes are sequenced across the first two to four weeks in coordination with the referring clinician wherever possible, and cross-tapers are documented against the same PHQ-9 timeline used for every other decision.

Insurance and admissions from Lake Worth Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and most BCBS plans. A verification of benefits is completed the same day admissions is called; the quote returned includes the deductible, coinsurance, and any prior-authorization requirements for PHP, IOP, rTMS, or ketamine services specifically, since those authorization pathways differ from general outpatient behavioral health coverage.

From Lake Worth Beach, admissions coordinators build the schedule around the client’s commute. Most Bryant Park and downtown residents drive I-95 to Linton Boulevard, and program hours are structured so IOP clients are back in Lake Worth by early afternoon. On-campus housing is available for clients who need PHP-level containment before stepping down to a commuter schedule, and family sessions can be scheduled in the evening when Lake Worth partners and adult children can attend without missing work.

Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.